Becton, Dickinson and Company (BDX) is a Healthcare stock trading at $143.96 (as of 2026-06-18), with a market capitalization of $40.12B and a trailing P/E of 36.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Becton, Dickinson and Company develops and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare providers, clinical laboratories, life science researchers, the pharmaceutical industry, and other customers worldwide. Its offerings span medical technologies and laboratory and diagnostic solutions, including products for injections, infusion and specimen collection, and related testing and workflow needs.